AnalystsJonathan Miller
Jonathan Miller's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 38%
#3472 out of 5510 analysts
Average Return
+0.01%
Win Rate
33%5 out of 15
Risk vs Reward
Poor
Good

Jonathan Miller's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Rayzebio IncRYZB
+212.14%$20.02$62.49
2023-10-11 -
2024-02-23
Buy
Gracell Biotechnologies IncGRCL
+89.81%$5.40$10.25
2023-11-27 -
2024-02-21
Buy
Gamida Cell LtdGMDAQ
+41.85%$4.54$6.44
2020-07-01 -
2021-07-01
Buy
Aura Biosciences IncAURA
+9.64%$6.38$7.00
2025-11-26 -
2026-09-11
Buy
Zymeworks IncZYME
+8.21%$24.25$26.24
2026-03-09 -
2026-09-11
Buy

Jonathan Miller Analyst Color

Get additional color on Jonathan Miller's coverage of popular stocks

Jonathan Miller's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Arvinas IncARVN
2Buy$14.00+65.68%Maintains
a month ago
Intellia Therapeutics IncNTLA
2Buy$24.00+104.43%Upgrades
a month ago
Zymeworks IncZYME
1Buy$48.00+82.93%Maintains
6 months ago
Caribou Biosciences IncCRBU
1Buy$13.00+923.62%Maintains
6 months ago
Atea Pharmaceuticals IncAVIR
1Buy$10.00+88.32%Maintains
6 months ago
Aura Biosciences IncAURA
1Buy$13.00+85.85%Reinstates
10 months ago
Gracell Biotechnologies IncGRCL
1BuyN/AN/AInitiates Coverage On
3 years ago
Rayzebio IncRYZB
1BuyN/AN/AInitiates Coverage On
3 years ago
Prokidney CorpPROK
1BuyN/AN/AInitiates Coverage On
4 years ago
Vaxxinity IncVAXX
1HoldN/AN/AInitiates Coverage On
4 years ago
Entrada Therapeutics IncTRDA
1BuyN/AN/AInitiates Coverage On
5 years ago
Shattuck Labs IncSTTK
1BuyN/AN/AInitiates Coverage On
6 years ago
Sqz Biotechnologies CoSQZB
1BuyN/AN/AInitiates Coverage On
6 years ago
Nanobiotix SaNBTX
1BuyN/AN/AInitiates Coverage On
6 years ago
Gamida Cell LtdGMDAQ
1BuyN/AN/AInitiates Coverage On
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.